Group 1 - The Shanghai Stock Exchange Science and Technology Innovation Board Medical Index (科创医疗) reported a value of 805.42 points, with a monthly increase of 10.37%, a three-month increase of 13.32%, and a year-to-date increase of 11.07% [1] - The index consists of no more than 30 listed companies in the medical field selected from the Science and Technology Innovation Board, reflecting the overall performance of medical listed companies [1] - The index is based on a reference date of December 30, 2022, with a base value of 1000.0 points [1] Group 2 - The top ten weighted companies in the index are: 惠泰医疗 (9.77%), 联影医疗 (9.36%), 热景生物 (7.33%), 爱博医疗 (6.23%), 奕瑞科技 (6.09%), 南微医学 (5.69%), 心脉医疗 (4.91%), 圣湘生物 (4.6%), 海尔生物 (3.79%), and 天智航 (3.3%) [1] - The index is fully composed of companies listed on the Shanghai Stock Exchange, with the following industry breakdown: medical consumables (43.55%), medical devices (29.18%), and in vitro diagnostics (27.26%) [2] - The index samples are adjusted quarterly, with adjustments implemented on the next trading day following the second Friday of March, June, September, and December [2]
上证科创板医疗指数报805.42点,前十大权重包含惠泰医疗等